What they were paid
Unicycive Therapeutics Director Compensation Table · the one fiscal year held| Fiscal year | Cash fees | Stock awards | Option awards | Other | Total |
|---|---|---|---|---|---|
| FY2025 | $65,000 | $0 | $84,486 | — | $149,486 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Unicycive Therapeutics, Inc. DEF 14A filed April 30, 2026, accession 0001213900-26-049690, and prior-year filings. Open the filing on EDGAR.
How this board is paid
company policy · FY2025Unicycive Therapeutics pays directors a $40,000 cash retainer and $50,000 in Options.
Committees
FY2025 · as the proxy prints themAudit · Compensation (Chair) · Nominating/Governance
The rest of the Unicycive Therapeutics board
FY2025 · as the company reported each| Director | Role | FY2025 total |
|---|---|---|
| Saraswati Kenkare-Mitra, Ph.D | Independent Director | $147,486 |
| Shalabh Gupta, M.D | Chair of the Board | $0 |
The full Unicycive Therapeutics compensation record
free company briefThis page is one director within Unicycive Therapeutics's record. The company brief lists every named executive and director, each linking to their own page.
Velarion Pro: every company page, peer tools and exports, one seat